Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia.
van Beek RD, de Muinck Keizer-Schrama SM, Hakvoort-Cammel FG, van der Sluis IM, Krenning EP, Pieters R, van den Heuvel-Eibrink MM. van Beek RD, et al. Among authors: van den heuvel eibrink mm, van der sluis im. Pediatr Blood Cancer. 2006 Jan;46(1):88-93. doi: 10.1002/pbc.20437. Pediatr Blood Cancer. 2006. PMID: 15926166
A prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.
Tong WH, Pieters R, Kaspers GJ, te Loo DM, Bierings MB, van den Bos C, Kollen WJ, Hop WC, Lanvers-Kaminsky C, Relling MV, Tissing WJ, van der Sluis IM. Tong WH, et al. Among authors: van den bos c, van der sluis im. Blood. 2014 Mar 27;123(13):2026-33. doi: 10.1182/blood-2013-10-534347. Epub 2014 Jan 21. Blood. 2014. PMID: 24449211 Free PMC article. Clinical Trial.
Drug-drug interactions in pediatric oncology patients.
Balk TE, van der Sijs IH, van Gelder T, Janssen JJB, van der Sluis IM, van Leeuwen RWF, Engels FK. Balk TE, et al. Among authors: van leeuwen rwf, van der sluis im, van der sijs ih, van gelder t. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26410. Epub 2017 Feb 16. Pediatr Blood Cancer. 2017. PMID: 28205376
Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients.
Sassen SD, Mathôt RA, Pieters R, Kloos RQ, de Haas V, Kaspers GJ, van den Bos C, Tissing WJ, Te Loo M, Bierings MB, Kollen WJ, Zwaan CM, van der Sluis IM. Sassen SD, et al. Among authors: van den bos c, van der sluis im. Haematologica. 2017 Mar;102(3):552-561. doi: 10.3324/haematol.2016.149195. Epub 2016 Nov 10. Haematologica. 2017. PMID: 28250007 Free PMC article.
Efficacy and safety of recombinant E. coli asparaginase in children with previously untreated acute lymphoblastic leukemia: A randomized multicenter study of the Dutch Childhood Oncology Group.
van der Sluis IM, de Groot-Kruseman H, Te Loo M, Tissing WJE, van den Bos C, Kaspers GJL, Bierings M, Kollen WJW, König T, Pichlmeier U, Kühnel HJ, Pieters R. van der Sluis IM, et al. Among authors: van den bos c. Pediatr Blood Cancer. 2018 Aug;65(8):e27083. doi: 10.1002/pbc.27083. Epub 2018 May 4. Pediatr Blood Cancer. 2018. PMID: 29727043 Clinical Trial.
112 results